2025’s AI Video Showdown: Comparing Google Veo 2 And OpenAI Sora
An expert comparison of OpenAI's Sora vs Google's Veo2 revealing which AI video tool offers better physics, interfaces and ...
Ophthalmology Times3h
FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.